Why the study?
Patients with diabetes are vulnerable to myocardial ischemia/reperfusion injury but unresponsive to ischemic post-conditioning, prompting investigation into whether decreased cardiac adiponectin causes this loss of cardioprotection.
Does ischemic post-conditioning (IPO) reduce myocardial ischemia-reperfusion injury in diabetic rats, and is this effect mediated by adiponectin?
Does ischemic post-conditioning (IPO) reduce myocardial ischemia-reperfusion injury in diabetic rats, and is this effect mediated by adiponectin?
The ineffectiveness of ischemic postconditioning in diabetic hearts is partially due to a decline in adiponectin and inactivation of Akt.
Adiponectin decline may underlie lost IPO efficacy in diabetic hearts; leaves open whether restoring APN reactivates cardioprotection in clinical diabetes.
PURPOSE: Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. METHODS: Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. RESULTS: Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). CONCLUSION: Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: